Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.


Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

Focal Therapy for Primary Localized Prostate Cancer Remains Investigational

Focal therapy for primary localized prostate cancer should remain investigational pending further study, according to a 2018 European Association of Urology (EAU) position paper.

Read more.

source: Journal of Clinical Pathways